Report overview
Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.
This report aims to provide a comprehensive presentation of the global market for Anti-Cathepsin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Cathepsin B. This report contains market size and forecasts of Anti-Cathepsin B in global, including the following market information:
Global Anti-Cathepsin B Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Anti-Cathepsin B market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Primary Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-Cathepsin B include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals and BOC Sciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Cathepsin B companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Cathepsin B Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Anti-Cathepsin B Market Segment Percentages, by Type, 2023 (%)
Primary Antibodies
Proteins and Peptides
Lysates
Global Anti-Cathepsin B Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Anti-Cathepsin B Market Segment Percentages, by Application, 2023 (%)
Cancer
Traumatic Brain Injury
Ebola Infection
Fertility Treatment
Others
Global Anti-Cathepsin B Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Anti-Cathepsin B Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Cathepsin B revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Anti-Cathepsin B revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Bio-Techne, BioVision Inc.
Santa Cruz Biotechnology, Inc.
MedChemExpress
BioCat GmbH
ApexBio Technology
Cayman Chemical
Selleck Chemicals
BOC Sciences
AG Scientific
Virobay Inc.
Abcam Plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Cathepsin B, market overview.
Chapter 2: Global Anti-Cathepsin B market size in revenue.
Chapter 3: Detailed analysis of Anti-Cathepsin B company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Cathepsin B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
